Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ETR vs GSK✓SelectedUSD · GSKETR vs GSK performance historyLatest closeAs of-0.11%11/13
Stock and ETF performance explorer

ETR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+156.3%
GSK return
+65.8%
Excess return
+90.4%
Maximum drawdown
-15.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.1%+0.5%-0.6%-0.2%
7D+1.2%+1.1%0.0%+1.0%
30D+7.0%+6.3%+0.7%+6.2%
3M+4.6%+1.8%+2.8%+4.3%
6M+0.1%+1.7%-1.5%-0.2%
YTD+23.2%+6.5%+16.6%+22.0%
1Y+20.6%+9.5%+11.1%+19.1%
3Y+156.3%+65.3%+91.0%+131.8%
All+156.3%+65.8%+90.4%+131.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling